Latest articles
No of your stocks has realtime/relevant news articles that can be accessed.
Take a look into our News feed to read about recent price changes and analysis.
Sentiment statistics ?
Financial Histories
Please use our Financial history templates to chart, read and compare all 10'Q filings in depth.
Overview
IDP.DEDay performance
| IDP.DE | |
|---|---|
| Price | 211.60 |
| Change Pct | 0.09 |
| Change Abs | 0.20 |
| Market Cap | 30.7 billion |
| Eps | 9.22 |
| Pe Ratio | 22.95 |
| Outstanding Shares | 144.9 million |
| Volume | 52 |
| Avg Volume | 97 |
| Industry | Drug Manufacturers—General |
| Sector Name | Health Care |
| Country Short Name | US |
| Announcement Earnings | 2024-02-13 13:30:00+00:00 |
Dividends
There is no dividend data to display. Refer our Dividend calendar for other accurate data.
Risk Profiles
Please sign up and become a member to view all risk profiles.
Peers
LLY.DE
GIS.DE
BRM.DE
3 Login now
4 Login now
Focus
Use our 'Focus' approach as text-and chart based summaries of the financial standing for a company. They are solely focussing on the company's market, risks and chances.
IDP.DE
Company descriptions
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy;